Manford M. Recent advances in epilepsy. J Neurol. 2017;264(8):1811–24.
Article PubMed PubMed Central Google Scholar
Piper RJ, Richardson RM, Worrell G, Carmichael DW, Baldeweg T, Litt B, et al. Towards network-guided neuromodulation for epilepsy. Brain. 2022;145(10):3347–62.
Article PubMed PubMed Central Google Scholar
Joris V, Weil AG, Fallah A. Brain surgery for medically intractable epilepsy. Adv Pediatr. 2022;69(1):59–74.
Hochbaum M, Kienitz R, Rosenow F, Schulz J, Habermehl L, Langenbruch L, et al. Trends in antiseizure medication prescription patterns among all adults, women, and older adults with epilepsy: a German longitudinal analysis from 2008 to 2020. Epilepsy Behav. 2022;130: 108666.
Kanner AM, Bicchi MM. Antiseizure medications for adults with epilepsy: a review. JAMA. 2022;327(13):1269–81.
Article CAS PubMed Google Scholar
Sauro KM, Wiebe S, Dunkley C, Janszky J, Kumlien E, Moshe S, et al. The current state of epilepsy guidelines: a systematic review. Epilepsia. 2016;57(1):13–23.
Moores G, D’Souza R, Bui E. Antiseizure medications and pregnancy. CMAJ. 2021;193(32):E1253.
Article PubMed PubMed Central Google Scholar
Jankovic SM, Dostic M. Choice of antiepileptic drugs for the elderly: possible drug interactions and adverse effects. Expert Opin Drug Metab Toxicol. 2012;8(1):81–91.
Article CAS PubMed Google Scholar
Hakami T. Neuropharmacology of antiseizure drugs. Neuropsychopharmacol Rep. 2021;41(3):336–51.
Article PubMed PubMed Central Google Scholar
Miranda AS, Miranda AS, Teixeira AL. Lamotrigine as a mood stabilizer: insights from the pre-clinical evidence. Expert Opin Drug Discov. 2019;14(2):179–90.
Strzelczyk A, Schubert-Bast S. Psychobehavioural and cognitive adverse events of anti-seizure medications for the treatment of developmental and epileptic encephalopathies. CNS Drugs. 2022;36(10):1079–111.
Article CAS PubMed PubMed Central Google Scholar
Steinhoff BJ, Klein P, Klitgaard H, Laloyaux C, Moseley BD, Ricchetti-Masterson K, et al. Behavioral adverse events with brivaracetam, levetiracetam, perampanel, and topiramate: a systematic review. Epilepsy Behav. 2021;118: 107939.
Mammi A, Ferlazzo E, Gasparini S, Bova V, Neri S, Labate A, et al. Psychiatric and behavioural side effects associated with perampanel in patients with temporal lobe epilepsy. a real-world experience. Front Neurol. 2022;13:839985.
Zhang CQ, He BM, Hu ML, Sun HB. Risk of valproic acid-related tremor: a systematic review and meta-analysis. Front Neurol. 2020;11: 576579.
Article PubMed PubMed Central Google Scholar
Callisto SP, Illamola SM, Birnbaum AK, Barkley CM, Bathena SPR, Leppik IE, et al. Severity of topiramate-related working memory impairment is modulated by plasma concentration and working memory capacity. J Clin Pharmacol. 2020;60(9):1166–76.
Article CAS PubMed PubMed Central Google Scholar
Ayalew MB, Muche EA. Patient reported adverse events among epileptic patients taking antiepileptic drugs. SAGE Open Med. 2018;6:2050312118772471.
Article PubMed PubMed Central Google Scholar
Bosak M, Slowik A, Iwanska A, Lipinska M, Turaj W. Co-medication and potential drug interactions among patients with epilepsy. Seizure. 2019;66:47–52.
Bruun E, Virta LJ, Kalviainen R, Keranen T. Co-morbidity and clinically significant interactions between antiepileptic drugs and other drugs in elderly patients with newly diagnosed epilepsy. Epilepsy Behav. 2017;73:71–6.
Hagemann A, Klimpel D, Bien CG, Brandt C, May TW. Influence of dose and antiepileptic comedication on brivaracetam serum concentrations in patients with epilepsy. Epilepsia. 2020;61(5):e43–8.
Article CAS PubMed Google Scholar
Hirsch LJ, Arif H, Buchsbaum R, Weintraub D, Lee J, Chang JT, et al. Effect of age and comedication on levetiracetam pharmacokinetics and tolerability. Epilepsia. 2007;48(7):1351–9.
Article CAS PubMed Google Scholar
May TW, Helmer R, Bien CG, Brandt C. Influence of dose and antiepileptic comedication on lacosamide serum concentrations in patients with epilepsy of different ages. Ther Drug Monit. 2018;40(5):620–7.
Article CAS PubMed Google Scholar
Weintraub D, Buchsbaum R, Resor SR Jr, Hirsch LJ. Effect of antiepileptic drug comedication on lamotrigine clearance. Arch Neurol. 2005;62(9):1432–6.
Vidaurre J, Gedela S, Yarosz S. Antiepileptic drugs and liver disease. Pediatr Neurol. 2017;77:23–36.
Ahmed SN, Siddiqi ZA. Antiepileptic drugs and liver disease. Seizure. 2006;15(3):156–64.
Hamed SA. The effect of antiepileptic drugs on the kidney function and structure. Expert Rev Clin Pharmacol. 2017;10(9):993–1006.
Article CAS PubMed Google Scholar
Körbel K, Rosenow F, Maltseva M, Müller H, Schulz J, Tsalouchidou PE, et al. Impact of COVID-19 pandemic on physical and mental health status and care of adults with epilepsy in Germany. Neurol Res Pract. 2022;4(1):44.
Article PubMed PubMed Central Google Scholar
Willems LM, Hochbaum M, Zöllner JP, Schulz J, Menzler K, Langenbruch L, et al. Trends in resource utilization and cost of illness in patients with active epilepsy in Germany from 2003 to 2020. Epilepsia. 2022;63(6):1591–602.
Mann C, Maltseva M, von Podewils F, Knake S, Kovac S, Rosenow F, et al. Supply problems of antiseizure medication are common among epilepsy patients in Germany. Epilepsy Behav. 2023;138: 108988.
Zöllner JP, Noda AH, McCoy J, Schulz J, Tsalouchidou PE, Langenbruch L, et al. Use of health-related apps and telehealth in adults with epilepsy in Germany: a multicenter cohort study. Telemed J E Health. 2022;29(4):540–50.
Willems LM, Hochbaum M, Frey K, Schulz J, Menzler K, Langenbruch L, et al. Multicenter, cross-sectional study of the costs of illness and cost-driving factors in adult patients with epilepsy. Epilepsia. 2022;63(4):904–18.
Strzelczyk A, Haag A, Reese JP, Nickolay T, Oertel WH, Dodel R, et al. Trends in resource utilization and prescription of anticonvulsants for patients with active epilepsy in Germany. Epilepsy Behav. 2013;27(3):433–8.
Willems LM, Richter S, Watermann N, Bauer S, Klein KM, Reese JP, et al. Trends in resource utilization and prescription of anticonvulsants for patients with active epilepsy in Germany from 2003 to 2013—a ten-year overview. Epilepsy Behav. 2018;9(83):28–35.
Benchimol EI, Smeeth L, Guttmann A, Harron K, Moher D, Petersen I, et al. The reporting of studies conducted using observational routinely-collected health data (RECORD) statement. PLoS Med. 2015;12(10): e1001885.
Article PubMed PubMed Central Google Scholar
von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP, et al. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Int J Surg. 2014;12(12):1495–9.
Panelli RJ, Kilpatrick C, Moore SM, Matkovic Z, D’Souza WJ, O’Brien TJ. The Liverpool Adverse Events Profile: relation to AED use and mood. Epilepsia. 2007;48(3):456–63.
Panelli RJ, Moore S, Kilpatrick C, Matkovic Z, D’Souza W, O’Brien T. The Liverpool adverse events profile (LAEP) reflects anxiety and depression rather than antiepileptic drug side effects in individual patients. Epilepsia. 2004;45:126.
Baker GA, Jacoby A, Francis P, Chadwick DW. The Liverpool adverse drug events profile. Epilepsia. 1995;36:S59.
Vary-O’Neal A, Miranzadeh S, Husein N, Holroyd-Leduc J, Sa’jobi TT, Wiebe S, et al. Association between frailty and antiseizure medication tolerability in older adults with epilepsy. Neurology. 2023;100(e1135):e1147.
Kwon OY, Park SP. Validity of the liverpool adverse events profile as a screening tool for detecting comorbid depression or anxiety disorder in people with epilepsy. J Epilepsy Res. 2018;8(2):74–80.
Article PubMed PubMed Central Google Scholar
Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361–70.
Article CAS PubMed Google Scholar
Gilliam FG, Barry JJ, Hermann BP, Meador KJ, Vahle V, Kanner AM. Rapid detection of major depression in epilepsy: a multicentre study. Lancet Neurol. 2006;5(5):399–405.
Bujang MA, Sa’at N, Sidik T, Joo
留言 (0)